Home / Pharmaceutical company intelligence
Pharmaceutical company intelligence

SKIMS PHARMACEUTICALS products and prices in Pakistan

Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.

Follow price changes 🔒 Company report (Pharma Pro)

Pharmaceutical manufacturer · Faisalabad · Pakistan

Pakistan pharmaceutical manufacturer specializing in branded generics across syrups, tablets, capsules, sachets and dry-powder suspensions.

SKIMS PHARMACEUTICALS products in Pakistan

SKIMS PHARMACEUTICALS has 37 medicine presentations registered in Pakistan under 14 brands, covering 15 generic medicines. Most of its products are in Anti-infectives, Pain & musculoskeletal and Gastrointestinal & hepatology. Its brands with the most registered strengths and packs are ACHLOR (Omeprazole), SKICIN (Ciprofloxacin), SKICON (Fluconazole) and SKIFEN (Ibuprofen). 37 products have an official DRAP price on MedInfoBase. See all 14 brands A to Z

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation11 Nov 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check7 Oct 2026Latest source-check date across this published portfolio
Latest effective price date6 Oct 2026Newest effective date among published current price records
Corporate profile evidence4 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Company type
Pharmaceutical manufacturer
Address
10-B, Value Addition City, Khurianwala, Faisalabad 38000, Pakistan · 38000
Phone
+92 41 8507350
Official contact
Contact page ↗
Corporate source details checked
16 Aug 2026
Corporate profile completeness
75%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000830 Skims Pharmaceuticals. · Punjab
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000830 37 linked products · source seen 11 Nov 2026 View source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx39public portfolio records represented
REG26unique registrations represented
IDX37indexed MedInfoBase presentations
SRC1additional source-observed presentations
R+1registry-only registrations
VER1registry-verified exact registrations
PKR37current validated price records
G15generic molecules in indexed catalogue
DF5dosage-form groups
TA4therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage95%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage100%
priced packs safely normalized per unit
Comparable-market coverage97%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixSKIMS PHARMACEUTICALSShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/skims-pharmaceuticalsGenerated 11 Nov 2026Anti-infectives23 · 62%Pain & musculoskeletal7 · 19%Gastrointestinal & hepatology5 · 14%Vitamins, minerals & nutrition2 · 5%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioSKIMS PHARMACEUTICALSDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/skims-pharmaceuticalsGenerated 11 Nov 202637presentationsSuspension17 · 46%Capsule11 · 30%Tablet6 · 16%Syrup2 · 5%Sachet1 · 3%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionSKIMS PHARMACEUTICALSCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/skims-pharmaceuticalsGenerated 11 Nov 202636comparable productsBelow peer median27 · 75%Near peer median5 · 14%Above peer median4 · 11%Company median price position-10.4%Lowest-price equivalents1Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsSKIMS PHARMACEUTICALSCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/skims-pharmaceuticalsGenerated 11 Nov 2026Shaigan Pharmaceuticals (Pvt) Ltd14 shared93% overlapSemos Pharmaceuticals PVT LTD14 shared93% overlapM/s. Genix Pharma (Pvt) Ltd.13 shared87% overlapMediate Pharmaceutical Pvt Ltd13 shared87% overlapGlobal Pharmaceuticals (Pvt.) Ltd.13 shared87% overlapValor Pharmaceuticals13 shared87% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Formulation footprint

Dosage forms

Suspension17 products
Capsule11 products
Tablet6 products
Syrup2 products
Sachet1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
🔒
MedInfoBase Pharma Pro

See where SKIMS PHARMACEUTICALS is priced against the market

36 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.

Below / near / above medianCompany price positionProduct examplesExcel, PDF & PowerPoint
Unlock with Pharma Pro
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock

Regulatory & price activity

Observed database signals

Indexed registration numbers24Distinct registrations among indexed, published, presentation-validated products only
Verified price observations72
Products with a verified price37
Products with multiple price observations35
Source records with multiple versions37
Latest portfolio source check7 Oct 2026
Latest effective price date6 Oct 2026
Latest source observation11 Nov 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

26 unique registration(s) · 37 indexed presentation(s) · 1 additional source-observed presentation(s) · 1 registry-only registration(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
ACHLOR Omeprazole 20 mg Capsule 14's 091482 PKR 250.32 PKR 17.88/capsule 🔒 Pharma Pro
ACHLOR Omeprazole 20 mg Capsule 10'S 091482 PKR 179.04 PKR 17.90/capsule 🔒 Pharma Pro
ACHLOR Omeprazole 20 mg Capsule 100'S 091482 PKR 1,715.69 PKR 17.16/capsule 🔒 Pharma Pro
ACHLOR Omeprazole 40 mg Capsule 14's 091483 PKR 434.57 PKR 31.04/capsule 🔒 Pharma Pro
ACHLOR Omeprazole 40 mg Capsule 10'S 091483 PKR 311.15 PKR 31.12/capsule 🔒 Pharma Pro
Artisun 120mg InjectionRegistry verified Artiva Injection 120mg — — — 138541Official source ↗ No indexed price — —
Dirazole Metronidazole 200 mg/5 mL Suspension 90ML 080431 PKR 83.43 PKR 0.93/mL 🔒 Pharma Pro
Dirazole Metronidazole 200 mg/5 mL Suspension 400ML 080431 PKR 340.71 PKR 0.85/mL 🔒 Pharma Pro
Dirazole Metronidazole 200 mg/5 mL Suspension 60ML 080431 PKR 55.62 PKR 0.93/mL 🔒 Pharma Pro
LEVOKIM Levofloxacin 250 mg Tablet 10'S 091466 PKR 434.57 PKR 43.46/tablet 🔒 Pharma Pro
LEVOKIM Levofloxacin 500 MG Tablet 10'S 091467 PKR 723.13 PKR 72.31/tablet 🔒 Pharma Pro
SKICIN Ciprofloxacin 250 MG Tablet 10'S 091463 PKR 226.10 PKR 22.61/tablet 🔒 Pharma Pro
SKICIN Ciprofloxacin 500 MG Tablet 10'S 091464 PKR 373.83 PKR 37.38/tablet 🔒 Pharma Pro
SKICIN Ciprofloxacin 750 MG Tablet 10'S 091465 PKR 399.80 PKR 39.98/tablet 🔒 Pharma Pro
SKICIN Ciprofloxacin 125 mg/5 mL Suspension 60 ML 121502 PKR 222.36 PKR 3.71/mL 🔒 Pharma Pro
SKICIN Ciprofloxacin 250 mg/5 mL Suspension 60 ml 121503 PKR 358.90 PKR 5.98/mL 🔒 Pharma Pro
SKICLAR Clarithromycin 125 MG/5 mL Suspension 60ML 091485 PKR 387.63 PKR 6.46/mL 🔒 Pharma Pro
SKICLAR Clarithromycin 250 MG/5 mL Suspension 60ML 091486 PKR 639.69 PKR 10.66/mL 🔒 Pharma Pro
SKICON Fluconazole 50 mg/5 mL Suspension 35ML 091460 PKR 365.04 PKR 10.43/mL 🔒 Pharma Pro
SKICON Fluconazole 150 mg Capsule 4's 119608 PKR 540.25 PKR 135.06/capsule 🔒 Pharma Pro
SKICON Fluconazole 150 mg Capsule 1's 119608 PKR 135.06 PKR 135.06/capsule 🔒 Pharma Pro
SKICON Fluconazole 150 mg Capsule 2's 119608 PKR 270.12 PKR 135.06/capsule 🔒 Pharma Pro
SKIDOX Doxycycline 100 mg Capsule 10X10'S 091451 PKR 677.94 PKR 6.78/capsule 🔒 Pharma Pro
SKIFEN Ibuprofen 100 mg/5 mL Suspension 90ML 080436 PKR 101.62 PKR 1.13/mL 🔒 Pharma Pro
SKIFEN Ibuprofen 100 mg Suspension 120ML 080436 PKR 135.50 PKR 1.13/mL 🔒 Pharma Pro
SKIFEN Ibuprofen 100 mg/5 mL Suspension 400ML 080436 PKR 433.60 PKR 1.08/mL 🔒 Pharma Pro
SKIFEN Ibuprofen 600 mg Sachet 4'S 096652 PKR 86.92 PKR 21.73/sachet 🔒 Pharma Pro
SKIFER Iron polymaltose complex 50 mg/5 mL Syrup 60mL 080438 PKR 115.96 PKR 1.93/mL 🔒 Pharma Pro
SKIFER Elemental Iron 50 mg Syrup 120mL 080438 PKR 220.31 PKR 1.84/mL No comparator
SKIMETHER Artemether + Lumefantrine 15 mg + 90 mg Dry suspension 60ML 091458 PKR 312.89 PKR 5.21/mL 🔒 Pharma Pro
SKIMOL Paracetamol 120 mg Suspension 100ML 080437 PKR 110.02 PKR 1.10/mL 🔒 Pharma Pro
SKIMOL Paracetamol 120 mg/5 mL Suspension 60ML 080437 PKR 66.01 PKR 1.10/mL 🔒 Pharma Pro
SKIMOL Paracetamol 120 mg/5 mL Suspension 400ML 080437 PKR 422.48 PKR 1.06/mL 🔒 Pharma Pro
SKIMOX Moxifloxacin 400 MG Tablet 5'S 091478 PKR 825.69 PKR 165.14/tablet 🔒 Pharma Pro
SKITRAN SYP (sulphamethoxazole +Source observed Trimethoprim — — 50ML 080435Official source ↗ No indexed price — —
SKIZIT Azithromycin 250 mg Capsule 6'S 091450 PKR 265.96 PKR 44.33/capsule 🔒 Pharma Pro
SKIZIT Azithromycin 250 mg Capsule 10'S 091450 PKR 443.27 PKR 44.33/capsule 🔒 Pharma Pro
SKIZIT Azithromycin 200 mg/5 mL Suspension 15ML 091456 PKR 286.82 PKR 19.12/mL 🔒 Pharma Pro
SKIZOL dry powder Linezolid 100 mg/5 mL Suspension 60ML 091461 PKR 608.40 PKR 10.14/mL 🔒 Pharma Pro
A to Z

All 14 SKIMS PHARMACEUTICALS brands in Pakistan

  • ACHLOR Omeprazole · 20 mg capsule, 40 mg capsule
  • Dirazole Metronidazole · 200 mg/5 mL suspension
  • LEVOKIM Levofloxacin · 250 mg tablet, 500 MG tablet
  • SKICIN Ciprofloxacin · 125 mg/5 mL suspension, 250 MG tablet, 250 mg/5 mL suspension
  • SKICLAR Clarithromycin · 125 MG/5 mL suspension, 250 MG/5 mL suspension
  • SKICON Fluconazole · 150 mg capsule, 50 mg/5 mL suspension
  • SKIDOX Doxycycline · 100 mg capsule
  • SKIFEN Ibuprofen · 100 mg suspension, 100 mg/5 mL suspension, 600 mg sachet
  • SKIFER Elemental Iron, Iron polymaltose complex · 50 mg syrup, 50 mg/5 mL syrup
  • SKIMETHER Artemether + Lumefantrine · 15 mg + 90 mg suspension
  • SKIMOL Paracetamol · 120 mg suspension, 120 mg/5 mL suspension
  • SKIMOX Moxifloxacin · 400 MG tablet
  • SKIZIT Azithromycin · 200 mg/5 mL suspension, 250 mg capsule
  • SKIZOL dry powder Linezolid · 100 mg/5 mL suspension
Questions

SKIMS PHARMACEUTICALS: common questions

How many products does SKIMS PHARMACEUTICALS have in Pakistan?

SKIMS PHARMACEUTICALS has 37 registered medicine presentations in Pakistan, sold under 14 brands and covering 15 generic medicines.

What are the main brands of SKIMS PHARMACEUTICALS?

By number of registered strengths and packs, its largest brands are ACHLOR (Omeprazole), SKICIN (Ciprofloxacin), SKICON (Fluconazole), SKIFEN (Ibuprofen) and Dirazole (Metronidazole). This is not a sales ranking.

Which therapy areas does SKIMS PHARMACEUTICALS cover?

The most products are in Anti-infectives (23), Pain & musculoskeletal (7), Gastrointestinal & hepatology (5) and Vitamins, minerals & nutrition (2).

Where can I see SKIMS PHARMACEUTICALS medicine prices?

Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.

MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). SKIMS PHARMACEUTICALS — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved November 11, 2026, from https://medinfobase.com/company/skims-pharmaceuticals/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.

Medicine brands A–Z:ABCDEFGHIJKLMNOPQRSTUVWXYZ0-9